Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid's BCR-ABL Ultra

Cepheid has begun shipping the CE-IVD marked Xpert BCR-ABL Ultra test to quantitate mRNA transcripts in patients with chronic myelogenous leukemia undergoing tyrosine kinase inhibitor treatment. The assay is an updated version of the Xpert BCR-ABL Monitor test that provides increased sensitivity, the firm said. It is aligned to the International Scale on a lot-to-lot basis, increasing reliability of comparisons between labs, and uses the Cepheid GeneXpert system to deliver results in less than two and a half hours. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.